July 29, 2020

Baseline Cardiometabolic Profiles and SARS-CoV-2 Risk in the UK Biobank

Category: Article Summary

Topic: Clinical Characteristics and Health Care Setting

• [pre-print, not peer-reviewed] Scalsky et al. examined the effect of cardiometabolic profiles on the risk of testing positive for SARS-CoV-2 among 9,005 UK Biobank participants. They found that elevated high density lipoprotein (HDL) was associated with reduced risk of testing positive for SARS-CoV-2 (aOR=0.85). Type II diabetes and HbA1c were associated with increased risk (OR=1.21 and 1.06), but the effects disappeared after controlling for HDL. 

Scalsky et al. (July 29, 2020). Baseline Cardiometabolic Profiles and SARS-CoV-2 Risk in the UK Biobank. Pre-print downloaded July 29 from https://doi.org/10.1101/2020.07.25.20161091